Ageing Research Reviews,
Journal Year:
2023,
Volume and Issue:
92, P. 102094 - 102094
Published: Oct. 18, 2023
As
a
global
public
health
problem,
low
back
pain
(LBP)
caused
by
intervertebral
disc
degeneration
(IDD)
seriously
affects
patients'
quality
of
life.
In
addition,
the
prevalence
IDD
tends
to
be
younger,
which
brings
huge
burden
individuals
and
society
economically.
Current
treatments
do
not
delay
or
reverse
progression
IDD.
The
emergence
biologic
therapies
has
brought
new
hope
for
treatment
Among
them,
extracellular
vesicles
(EVs),
as
nanoscale
bioactive
substances
that
mediate
cellular
communication,
have
now
produced
many
surprising
results
in
research
This
article
reviews
mechanisms
roles
EVs
delaying
describes
prospects
challenges
EVs.
Advanced Science,
Journal Year:
2024,
Volume and Issue:
11(13)
Published: Jan. 29, 2024
Abstract
Delayed
wound
healing
is
a
major
complication
of
diabetes,
and
associated
with
impaired
cellular
functions.
Current
treatments
are
unsatisfactory.
Based
on
the
previous
reports
microRNA
expression
in
small
extracellular
vesicles
(sEVs),
miR‐17‐5p‐engineered
sEVs
(sEVs
17‐OE
)
encapsulated
them
gelatin
methacryloyl
(GelMA)
hydrogel
for
diabetic
wounds
treatment
fabricated.
SEVs
successfully
fabricated
16‐fold
increase
miR‐17‐5p
expression.
inhibited
senescence
promoted
proliferation,
migration,
tube
formation
high
glucose‐induced
human
umbilical
vein
endothelial
cells
(HG‐HUVECs).
Additionally,
also
performs
promotive
effect
dermal
fibroblasts
(HG‐HDFs).
Mechanism
analysis
showed
expressions
p21
phosphatase
tensin
homolog
(PTEN),
as
target
genes
miR‐17‐5p,
downregulated
significantly
by
.
Accordingly,
downstream
pathways
PTEN,
activated.
Next,
loaded
GelMA
to
fabricate
novel
bioactive
dressing
evaluate
their
effects
healing.
Gel‐sEVs
effectively
accelerated
promoting
angiogenesis
collagen
deposition.
The
mechanism
may
be
local
cell
proliferation.
Therefore,
loading
hydrogel,
offering
an
option
chronic
management
World Journal of Stem Cells,
Journal Year:
2022,
Volume and Issue:
14(7), P. 453 - 472
Published: July 26, 2022
The
use
of
mesenchymal
stem-cells
(MSC)
in
cell
therapy
has
received
considerable
attention
because
their
properties.
These
properties
include
high
expansion
and
differentiation
vitro,
low
immunogenicity,
modulation
biological
processes,
such
as
inflammation,
angiogenesis
hematopoiesis.
Curiously,
the
regenerative
effect
MSC
is
partly
due
to
paracrine
activity.
This
prompted
numerous
studies,
investigate
therapeutic
potential
secretome
general,
specifically
extracellular
vesicles
(EV).
latter
contain
proteins,
lipids,
nucleic
acids,
other
metabolites,
which
can
cause
physiological
changes
when
released
into
recipient
cells.
Interestingly,
contents
EV
be
modulated
by
preconditioning
under
different
culture
conditions.
Among
them,
exposure
hypoxia
stands
out;
these
cells
respond
activating
hypoxia-inducible
factor
(HIF)
at
O2
concentrations.
HIF
direct
indirect
pleiotropic
effects,
modulating
expression
hundreds
genes
involved
processes
migration,
proliferation,
differentiation,
angiogenesis,
metabolism,
apoptosis.
Expression
reflected
secreted
EV.
studies
show
that
MSC-derived
conditioned
have
a
higher
capacity
than
those
obtained
normoxia.
In
this
review,
we
implications
responses
relation
tissue
regeneration.
addition,
being
evaluated
very
attractive
strategy
for
isolation
EV,
with
clinical
medicine
applied
pathologies.
Bioactive Materials,
Journal Year:
2023,
Volume and Issue:
27, P. 257 - 270
Published: April 14, 2023
Neutrophil
extracellular
traps
(NETs)
have
been
considered
a
significant
unfavorable
factor
for
wound
healing
in
diabetes,
but
the
mechanisms
remain
unclear.
The
therapeutic
application
of
small
vesicles
(sEVs)
derived
from
mesenchymal
stem
cells
(MSCs)
has
received
considerable
attention
their
properties.
Hypoxic
preconditioning
is
reported
to
enhance
potential
MSC-derived
sEVs
regenerative
medicine.
Therefore,
aim
this
study
illustrate
detailed
mechanism
NETs
impairment
diabetic
and
develop
promising
NET-targeting
treatment
based
on
hypoxic
pretreated
(Hypo-sEVs).
Excessive
were
found
wounds
high
glucose
(HG)-induced
neutrophils.
Further
research
showed
that
concentration
impaired
function
fibroblasts
through
activating
endoplasmic
reticulum
(ER)
stress.
Hypo-sEVs
efficiently
promoted
reduced
excessive
NET
formation
by
transferring
miR-17-5p.
Bioinformatic
analysis
RNA
interference
experiment
revealed
miR-17-5p
obstructed
targeting
TLR4/ROS/MAPK
pathway.
Additionally,
overexpression
decreased
overcame
NET-induced
fibroblasts,
similar
effects
Hypo-sEVs.
Overall,
we
identify
previously
unrecognized
NET-related
provide
strategy
treatment.
Biomedicine & Pharmacotherapy,
Journal Year:
2024,
Volume and Issue:
172, P. 116238 - 116238
Published: Feb. 3, 2024
Intervertebral
disc
degeneration
(IDD)
is
a
disease
that
severely
affects
spinal
health
and
prevalent
worldwide.
Mesenchymal
stem
cells
(MSCs)
their
derived
extracellular
vesicles
(EVs)
have
regenerative
potential
emerged
as
promising
therapeutic
tools
for
treating
degenerative
discs.
However,
challenges
such
the
harsh
microenvironment
of
degenerated
intervertebral
discs
EVs'
limited
stability
efficacy
hindered
clinical
application.
In
recent
years,
hydrogels
attracted
much
attention
in
field
IDD
therapy
because
they
can
mimic
physiologic
provide
solution
by
providing
suitable
growth
environment
MSCs
EVs.
This
review
introduced
biological
properties
EVs,
summarized
research
on
application
EVs
IDD,
current
trial
studies
also
explored
mechanism
action
addition,
plenty
elaborated
different
classified
tissue
engineering,
synergistic
effect
promoting
regeneration,
wide
IDD.
Finally,
problems
still
faced
hydrogel-loaded
treatment
are
summarized,
solutions
proposed.
paper
outlines
effects
combination
with
aims
to
theoretical
references
future
related
studies.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 10, 2025
Mesenchymal
stem
cells
(MSCs)
and
MSC-derived
extracellular
vesicles
(MSC-EVs)
are
increasingly
recognized
for
their
therapeutic
potential
in
regenerative
medicine,
driven
by
capabilities
immunomodulation
tissue
repair.
However,
MSCs
present
risks
such
as
immunogenic
responses,
malignant
transformation,
the
to
transmit
infectious
pathogens
due
intrinsic
proliferative
differentiative
abilities.
In
contrast,
MSC-EVs,
particularly
exosomes
(MSC-exosomes,
30–150
nm
diameter),
offer
a
safer
profile.
These
acellular
mitigate
associated
with
immune
rejection
tumorigenesis
inherently
incapable
of
forming
ectopic
tissues,
thereby
enhancing
clinical
safety
applicability.
This
review
highlights
promise
MSC-exosomes
especially
focusing
on
modulation
miRNA
(one
bioactive
molecules
MSC-EVs)
profiles
through
various
preconditioning
strategies
exposure
hypoxia,
chemotherapeutic
agents,
inflammatory
cytokines,
physical
stimuli.
Such
conditioning
is
shown
optimize
potential.
Key
miRNAs
including
miR-21,
miR-146,
miR-125a,
miR-126,
miR-181a
noted
roles
facilitating
repair
modulating
responses.
functionalities
position
valuable
tool
personalized
case
exosome-based
interventions.
Despite
this
also
acknowledged
limitations
traditional
MSC
therapies
advocates
strategic
pivot
towards
modalities
enhance
outcomes.
By
discussing
recent
advances
detail
identifying
remaining
pitfalls,
aims
guide
future
directions
improving
efficacy
MSC-exosome-based
therapeutics.
Additionally,
variability
MSC-EVs
presents
challenges
diverse
play
regulating
gene
expression
cell
behavior.
The
content
can
be
influenced
differences
isolation
purification
methods,
which
may
alter
specific
miRNAs,
contributing
effects.